| Primary |
| Multiple Myeloma |
22.0% |
| Prophylaxis |
12.0% |
| Product Used For Unknown Indication |
10.5% |
| Ovarian Cancer |
10.4% |
| Ovarian Cancer Recurrent |
7.8% |
| Drug Use For Unknown Indication |
6.6% |
| Acute Lymphocytic Leukaemia |
3.3% |
| Nausea |
2.8% |
| Breast Cancer |
2.7% |
| T-cell Lymphoma |
2.7% |
| Hypertension |
2.5% |
| Constipation |
2.4% |
| Pain |
2.4% |
| Interstitial Lung Disease |
2.0% |
| Burkitt's Lymphoma |
1.8% |
| Breast Cancer Metastatic |
1.8% |
| Premedication |
1.7% |
| Stomatitis |
1.7% |
| Diffuse Large B-cell Lymphoma |
1.6% |
| Hiv Infection |
1.5% |
|
| Interstitial Lung Disease |
13.2% |
| Vomiting |
6.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
6.5% |
| Ovarian Cancer |
6.2% |
| Off Label Use |
5.9% |
| Pyrexia |
5.7% |
| Infusion Related Reaction |
5.1% |
| Death |
4.9% |
| Myocardial Infarction |
4.9% |
| Sepsis |
4.9% |
| White Blood Cell Count Decreased |
4.9% |
| Stomatitis |
4.6% |
| Rash |
3.8% |
| Renal Failure Acute |
3.8% |
| Pulmonary Embolism |
3.5% |
| Syncope |
3.5% |
| Nausea |
3.2% |
| Renal Failure |
3.2% |
| Carbohydrate Antigen 125 Increased |
3.0% |
| Respiratory Failure |
2.7% |
|
| Secondary |
| Multiple Myeloma |
24.1% |
| Prophylaxis |
15.3% |
| Product Used For Unknown Indication |
8.2% |
| Ovarian Cancer Recurrent |
8.1% |
| Drug Use For Unknown Indication |
6.3% |
| Ovarian Cancer |
5.9% |
| Hiv Infection |
3.9% |
| T-cell Lymphoma |
3.6% |
| Interstitial Lung Disease |
3.0% |
| Mycobacterium Avium Complex Infection |
2.8% |
| Stomatitis |
2.8% |
| Constipation |
2.3% |
| Nausea |
2.3% |
| Plasma Cell Myeloma |
2.0% |
| Disseminated Intravascular Coagulation |
1.9% |
| Hypertension |
1.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
1.6% |
| Back Pain |
1.6% |
| Pain |
1.3% |
| Herpes Zoster |
1.3% |
|
| Vomiting |
13.8% |
| White Blood Cell Count Decreased |
9.1% |
| Interstitial Lung Disease |
9.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
9.0% |
| Platelet Count Decreased |
6.7% |
| Death |
5.0% |
| Thrombocytopenia |
5.0% |
| Pyrexia |
4.7% |
| Pneumonia |
4.5% |
| Neutropenia |
3.4% |
| Ovarian Cancer Recurrent |
3.4% |
| Nausea |
3.2% |
| Stomatitis |
3.2% |
| Ulcer |
3.2% |
| Pulmonary Embolism |
3.0% |
| Renal Failure Acute |
3.0% |
| Respiratory Failure |
3.0% |
| Ovarian Cancer |
2.8% |
| Keratitis |
2.6% |
| Weight Decreased |
2.6% |
|
| Concomitant |
| Multiple Myeloma |
29.6% |
| Drug Use For Unknown Indication |
15.4% |
| Pain |
9.3% |
| Product Used For Unknown Indication |
8.2% |
| Breast Cancer |
7.1% |
| Metastases To Bone |
6.1% |
| Ovarian Cancer |
4.6% |
| Plasma Cell Myeloma |
2.4% |
| Hypertension |
2.1% |
| Insomnia |
2.1% |
| Deep Vein Thrombosis |
1.6% |
| Anaemia |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Osteoporosis |
1.4% |
| Anxiety |
1.3% |
| Hiccups |
1.2% |
| T-cell Lymphoma |
1.2% |
| Nausea |
1.2% |
| Breast Cancer Metastatic |
1.1% |
| Chemotherapy |
1.1% |
|
| Weight Decreased |
25.1% |
| Vomiting |
13.4% |
| Wound Drainage |
9.2% |
| Tooth Extraction |
7.4% |
| White Blood Cell Count Decreased |
4.6% |
| Walking Aid User |
4.2% |
| Wound Complication |
3.5% |
| Wheezing |
3.2% |
| Death |
2.8% |
| Osteonecrosis |
2.8% |
| Pneumonia |
2.8% |
| Toothache |
2.8% |
| Wound Infection Staphylococcal |
2.8% |
| Thrombocytopenia |
2.5% |
| Urge Incontinence |
2.5% |
| Visual Field Defect |
2.5% |
| Sepsis |
2.1% |
| Vein Disorder |
2.1% |
| Platelet Count Decreased |
1.8% |
| Pyrexia |
1.8% |
|
